Diabetes mellitus and active tuberculosis disease: Clinical presentation and treatment outcomes in adult tuberculosis patients Open Access
Magee, Matthew James (2013)
Published
Abstract
Objectives: Tuberculosis (TB) and diabetes mellitus (DM) contribute to extensive global morbidity and mortality. Although DM is an accepted risk factor for developing active TB disease, less is known about the relation between DM and TB clinical characteristics, including TB disease presentation and TB treatment outcomes. The overall goal of this dissertation was to estimate the association between DM and 1) TB disease severity at the time of TB diagnosis and 2) poor TB clinical outcomes. Methods: This dissertation included three studies, each examined a subset of specific aims comparing TB disease in patients with and without DM. Study 1 was a cohort of new adult TB patients from Tbilisi, Georgia, screened for DM and impaired glucose tolerance (pre-DM) using a point-of-care hemoglobin A1c (HbA1c) test. We compared measures of TB severity at clinical presentation (including lung cavitary disease, sputum smear grade, and hemoptysis) in patients with and without DM. In study 2, we estimated the association between DM and time to sputum culture conversion in a cohort of multidrug-resistant (MDR) TB patients from the country of Georgia. Study 3 estimated the association between DM and time to all-cause mortality during TB treatment in a cohort of adult TB patients from the state of Georgia, United States. Results: Study 1 demonstrated that patients with TB and DM were more likely to present with higher sputum smear grade (adjusted odds ratio 2.63, 95% confidence interval [CI] 1.14--6.06) compared to TB patients without DM. In study 2, the estimated hazard of sputum culture conversion was modestly, but non-significantly, lower in MDR TB patients with DM compared to those without DM (adjusted hazard ratio [aHR] 0.93, 95% CI 0.71--1.23). Compared to TB patients without DM, Study 3 reported TB-DM patients did not have significantly greater hazard of all-cause mortality during TB treatment (aHR 1.22, 95% CI 0.70--2.12). Conclusion: Adult TB patients with DM may have more severe TB disease at clinical presentation. However, our findings did not suggest that DM has a clinically meaningful impact on time to TB culture conversion or all-cause mortality during TB treatment.
Table of Contents
Table of Contents
CHAPTER 1: INTRODUCTION TO TUBERCULOSIS AND
DIABETES MELLITUS EPIDEMIOLOGY 1
Background 5
Biologic plausibility 23
Summary 27
Chapter 1 references 37
CHAPTER 2: DIABETES MELLITUS AND TUBERCULOSIS SEVERITY
IN THE COUNTRY OF GEORGIA 52
Introduction 53
Methods 54
Results 57
Discussion 59
Chapter 2 references 74
CHAPTER 3: CULTURE CONVERSION AMONG MULITDRUG-
RESISTANT TUBERCULOSIS PATIENTS WITH DIABETES
MELLITUS 79
Introduction 80
Methods 81
Results 85
Discussion 87
Chapter 3 references 102
CHAPTER 4: MORTALITY DURING TUBERCULOSIS TREATMENT
AMONG PATIENTS WITH DIABETES MELLITUS IN THE STATE OF
GEORGIA 107
Introduction 108
Methods 109
Results 112
Discussion 113
Chapter 4 references 124
CHAPTER 5: SUMMARY AND CONCLUSIONS 128
Strengths and limitations 129
Remaining gaps in knowledge and future research recommendations 132
Public health and clinical implications 135
Chapter 5 references 138
About this Dissertation
School | |
---|---|
Department | |
Degree | |
Submission | |
Language |
|
Research Field | |
Keyword | |
Committee Chair / Thesis Advisor | |
Committee Members |
Primary PDF
Thumbnail | Title | Date Uploaded | Actions |
---|---|---|---|
|
Diabetes mellitus and active tuberculosis disease: Clinical presentation and treatment outcomes in adult tuberculosis patients () | 2018-08-28 14:33:01 -0400 |
|
Supplemental Files
Thumbnail | Title | Date Uploaded | Actions |
---|